Correlation Between Reneo Pharmaceuticals and C4 Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Reneo Pharmaceuticals and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reneo Pharmaceuticals and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reneo Pharmaceuticals and C4 Therapeutics, you can compare the effects of market volatilities on Reneo Pharmaceuticals and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reneo Pharmaceuticals with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reneo Pharmaceuticals and C4 Therapeutics.

Diversification Opportunities for Reneo Pharmaceuticals and C4 Therapeutics

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Reneo and CCCC is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Reneo Pharmaceuticals and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Reneo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reneo Pharmaceuticals are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Reneo Pharmaceuticals i.e., Reneo Pharmaceuticals and C4 Therapeutics go up and down completely randomly.

Pair Corralation between Reneo Pharmaceuticals and C4 Therapeutics

If you would invest  1,820  in Reneo Pharmaceuticals on September 27, 2024 and sell it today you would earn a total of  0.00  from holding Reneo Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Reneo Pharmaceuticals  vs.  C4 Therapeutics

 Performance 
       Timeline  
Reneo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Strong
Over the last 90 days Reneo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very unsteady technical indicators, Reneo Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.
C4 Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days C4 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Reneo Pharmaceuticals and C4 Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Reneo Pharmaceuticals and C4 Therapeutics

The main advantage of trading using opposite Reneo Pharmaceuticals and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reneo Pharmaceuticals position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.
The idea behind Reneo Pharmaceuticals and C4 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
CEOs Directory
Screen CEOs from public companies around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA